Surgery and Anesthesia in Patients with Pulmonary Hypertension.


Journal

Seminars in respiratory and critical care medicine
ISSN: 1098-9048
Titre abrégé: Semin Respir Crit Care Med
Pays: United States
ID NLM: 9431858

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 1 11 2023
pubmed: 21 9 2023
entrez: 20 9 2023
Statut: ppublish

Résumé

Pulmonary hypertension is characterized by right ventricular impairment and a reduced ability to compensate for hemodynamic insults. Consequently, surgery can be challenging but is increasingly considered in view of available specific therapies and improved longer term survival. Optimal management requires a multidisciplinary patient-centered approach involving surgeons, anesthetists, pulmonary hypertension clinicians, and intensivists. The optimal pathway involves risk:benefit assessment for the proposed operation, optimization of pulmonary hypertension and any comorbidities, the appropriate anesthetic approach for the specific procedure and patient, and careful monitoring and management in the postoperative period. Where patients are carefully selected and meticulously managed, good outcomes can be achieved.

Identifiants

pubmed: 37729924
doi: 10.1055/s-0043-1772753
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

797-809

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

R.C. has received speakers fees and funding for conference travel from Janssen and MSD. D.G.K. has received consulting, speakers and advisory board fees from Janssen, MSD, Ferrer, and United Therapeutics. His department has also received research grants from Janssen and Ferrer.

Auteurs

Robin Condliffe (R)

Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.

Ruth Newton (R)

Department of Anaesthesia, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom.

Kris Bauchmuller (K)

Department of Critical Care, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom.

Tessa Bonnett (T)

Department of Obstetrics and Gynaecology, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom.

Robert Kerry (R)

Department of Orthopaedics, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom.

Alexa Mannings (A)

Department of Anaesthesia, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom.

Amanda Nair (A)

Department of Anaesthesia, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom.

Karen Selby (K)

Department of Obstetrics and Gynaecology, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom.

Paul P Skinner (PP)

Department of Surgery, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom.

Victoria J Wilson (VJ)

Department of Anaesthesia, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom.

David G Kiely (DG)

Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH